The diagnostic significance of glucose-6-phosphate isomerase (G6PI) antigen and anti-G6PI antibody in rheumatoid arthritis patients


Objective: To investigate whether glucose-6-phosphate isomerase (G6PI) antigen and anti-G6PI antibodies could be applied for the clinical diagnostic markers of rheumatoid arthritis (RA) and its associations with RA activity states. Methods: The levels of G6PI antigens and anti-G6PI Abs in sera from 176 RA patients in different states, 35 non-RA patients and 100 healthy donors and in synovia fluids from 33 patients and 11 non-RA patients were measured by ELISA. Results: The sensitivity and specificity of G6PI antigens in the RA patients were 75.0% and 93.3%, respectively. The levels of serum G6PI antigens in 176 RA patients were significantly higher than non-RA patients and the health controls. Especially, there was a significant difference between the active phase and the inactive phase in G6PI antigens levels. The levels of G6PI antigens in synovia fluid were also significantly higher in RA groups than in non-RA patients. With the values of the anti-G6PI Abs in sera, there were no marked differences among RA, non-RA patients and health controls. Also, there was no significant difference between the active phase and the inactive phase in RA patients. However, there were no significant differences of G6PI and anti-G6PI between RA patients and health controls in synovial fluid. Conclusions: G6PI is highly correlated with the activity states of RA, and could be applied for a clinical biomarker with high sensitivity and specificity for the diagnosis of RA.

Share and Cite:

Yang, D. , Ge, H. , Dong, J. , Zhu, X. , Sun, G. , Ouyang, W. , Wang, L. and Zhang, G. (2013) The diagnostic significance of glucose-6-phosphate isomerase (G6PI) antigen and anti-G6PI antibody in rheumatoid arthritis patients. Advances in Bioscience and Biotechnology, 4, 818-822. doi: 10.4236/abb.2013.48108.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Lacotte, S., Brun, S., Muller, S. and Dumortier, H. (2009) CXCR3, inflammation, and autoimmune diseases. Annals of the New York Academy of Sciences, 1173, 310-317. doi:10.1111/j.1749-6632.2009.04813.x
[2] Sherer, Y. and Shoenfeld, Y. (2006) Mechanisms of disease: Atherosclerosis in autoimmune diseases. Nature Clinical Practice Rheumatology, 2, 99-106. doi:10.1038/ncprheum0092
[3] Firestein, G.S. (2003) Evolving concepts of rheumatoid arthritis. Nature, 423, 356-361. doi:10.1038/nature01661
[4] Gabriel, S.E. and Michaud, K. (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Research & Therapy, 11, 229. doi:10.1186/ar2669
[5] Matsumoto, I., Staub, A., Banjoist, C. and Mathis D. (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science, 286, 1732-1735. doi:10.1126/science.286.5445.1732
[6] Schaller, M., Burton, D.R. and Ditzel, H.J. (2001) Autoantibodies to G6PI in rheumatoid arthritis: Linkage between an animal model and human disease. Nature Immunology, 2, 746-753. doi:10.1038/90696
[7] Schaller, M., Stohl, W., Tan, S.M., Benoit, V.M., Hilbert, D.M. and Ditzel H.J. (2005) Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Annals of the Rheumatic Diseases, 64, 743-749. doi:10.1136/ard.2004.025502
[8] Schaller, M., Stohl, W., Benoit, V., Tan, S.M., Johansen, L. and Ditzel H.J. (2006) Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI). Biochemical and Biophysical Research Communications, 349, 838-845. doi:10.1016/j.bbrc.2006.08.105
[9] Fan, L.Y., Zong, M., Wang, Q., Yang, L., Sun, L.S., Ye, Q., Ding, Y.Y. and Ma, J.W. (2010) Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis. Clinica Chimica Acta, 411, 2049-2053. doi:10.1016/j.cca.2010.08.043
[10] Kassahn, D., Kolb, C., Solomon, S., Bochtler, P. and Illges, H. (2002) Few human autoimmune sera detect GPI. Nature Immunology, 3, 411-412. doi:10.1038/ni0502-411b
[11] Schubert, D., Schmidt, M., Zaiss, D., Jungblut, P.R. and Kamradt, T. (2002) Autoantibodies against GPI and creatine kinase in rheumatoid arthritis. Nature Immunology, 3, 411. doi:10.1038/ni0502-411a
[12] Herve, C.A., Wait, R. and Venables, P.J. (2003) Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology, 8, 986-988. doi:10.1093/rheumatology/keg271
[13] Matsumoto, I., Lee, D.M., Goldbach-Mansky, R., Sumida, T., Hitchon, C.A., Schur, P.H., Anderson, R.J., Coblyn, J.S., Weinblatt, M.E., Brenner, M., Duclos, B., Pasquali, J.L., El-Gabalawy, H., Mathis, D. and Benoist, C. (2003) Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis & Rheumatism, 48, 944-954. doi:10.1002/art.10898
[14] Klippel, J.H., Crofford, L.J.C., Stone, J.H. and Weyand, C.M. (2001) Primer on the rheumatic diseases. 12th Edition, Arthritis Foundation, Atlanta.
[15] Kraus, A.P., Langston Jr., M.F. and Lynch, B.L. (1968) Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia. Biochemical and Biophysical Research Communications, 30, 173-177. doi:10.1016/0006-291X(68)90466-X
[16] Yu, F.L., Liao, M.H., Lee, J.W. and Shin W.L. (2004) Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3. Biochemical and Biophysical Research Communications, 314, 76-82. doi:10.1016/j.bbrc.2003.12.056

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.